Skip to content
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Clinical Topics
View All
Addiction
Anxiety
Bipolar Disorder
Depression
Difficult to Treat Depression
Neurology
OCD
Psychopharmacology
PTSD and Trauma
Schizophrenia
Tardive Dyskinesia
View All
Collections
View All
Academic Highlights
Auvelity: Information from Industry
Banner Alzheimer’s Institute
Clinical & Practical Psychopharmacology
Early Career Psychiatrists
Focus on Childhood and Adolescent Mental Health
Focus on Geriatric Psychiatry
Focus on Psychotherapy
Focus on Suicide
Focus on Psychosis
Focus on Women’s Mental Health
Rounds in the General Hospital
Josephine Cucchiaro, PhD
JCP
Original Research
Lurasidone in Early Nonresponding Schizophrenia
December 28, 2016
What's the next step when a patient doesn' t respond to an antipsychotic? Should you augment, switch medications, wait and see, or raise the dose? Read this study in...
Antony Loebel
,
Robert Silva
,
Robert Goldman
, et al
JCP
Original Research
Lurasidone in Older Adults With Bipolar Depression
October 26, 2016
Lurasidone's favorable safety profile in younger adults suggests it would be a good candidate for the treatment of episodes of bipolar depression in older adults. For your patients 55...
Martha Sajatovic
,
Brent P. Forester
,
Joyce Tsai
, et al
JCP
Original Research
Lurasidone and Bipolar Depression
April 22, 2015
Read the analysis of a randomized placebo-controlled trial of Lurasidone in the Treatment of Bipolar Depression With Mixed (Subsyndromal Hypomanic) Features.
Roger S. McIntyre
,
Josephine Cucchiaro
,
Andrei Pikalov
, et al
JCP
Original Research
Effectiveness of Lurasidone for Patients With Schizophrenia Following 6 Weeks of Acute Treatment With Lurasidone, Olanzapine, or Placebo: A 6-Month, Open-Label, Extension Study
March 13, 2013
Stephen M. Stahl
,
Josephine Cucchiaro
,
Doreen Simonelli
, et al
JCP
Original Research
Effectiveness of Lurasidone in Patients with Schizophrenia or Schizoaffective Disorder Switched From Other Antipsychotics: A Randomized, 6-Week, Open-Label Study
January 15, 2013
Joseph P. McEvoy
,
Leslie Citrome
,
David Hernandez
, et al
JCP
Original Research
Lurasidone in the Treatment of Acute Schizophrenia: A Double-Blind, Placebo-Controlled Trial
June 2, 2009
Mitsutaka Nakamura
,
Masaaki Ogasa
,
John Guarino
, et al